A Jackson has been good for CTIX in that he also authored the seekingalpha article "Pfizer Eyes CTIX"?

The current article is very well written and does delve into the upside value potential for CTIX which is far and above what anybody to date has dared to mention.

The best part is there is no sensationalism in the article, just clear statements of fact as to current events and results.

IMO it makes an early effort at buying out CTIX by big pharma much more likely as they have to realize the value of the potential alone for all these KEVETRIN cocktail products will be beyond belief.

If KEVETRIN proves itself in PH1, we could be among the luckiest investors of all time.